Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Annals of the Rheumatic Diseases
|
July 23, 2013
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients
P C E Hissink Muller, J Anink, J Shi, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Annals of the Rheumatic Diseases
|
November 10, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.
The Lancet. Rheumatology
|
March 23, 2022
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Journal of Allergy and Clinical Immunology
|
May 19, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Annals of the Rheumatic Diseases
|
July 23, 2013
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients
P C E Hissink Muller, J Anink, J Shi, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Annals of the Rheumatic Diseases
|
November 10, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.
The Lancet. Rheumatology
|
March 23, 2022
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Journal of Allergy and Clinical Immunology
|
May 19, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, et al.
Page
of 9